Stimulus Funding Supports Human Proteome Detection and Quantitation (hPDQ) Pilot Project
Drs. Amanda Paulovich (Fred Hutchinson Cancer Research Center) and Steve Carr (The Broad Institute of MIT and Harvard) have received Recovery Act funding in support of a hPDQ pilot project. If this pilot is successful, the research community will have the means to assess all proteins across all disease states, profoundly impacting healthcare outcomes. Read more.
CPTC Presentation to NCI’s Board of Scientific Advisors Webcast
In June of this year, members of the CPTC community provided a program update to NCI’s Board of Scientific Advisors (BSA), which was very well received. Read more.
Newly Expanded Reagents Data Portal Now Available
The Reagents Data Portal is rapidly expanding as the CPTC initiative makes way for numerous reagents and resources in the pipeline that are greatly needed for effective proteomic analysis. Come visit the newly revamped portal!
The 3rd Annual CPTC Meeting
CPTC held its third annual meeting in Bethesda, MD, on October 7-9, 2008, bringing together more than 200 participants—twice as many compared to last year—representing the full gamut of scientific organizations that make up the CPTC community.
CPTC Prepares Online Video Protocols for Journal of Visualized Experiments
Working with the Journal of Visualized Experiments (JoVE), CPTC researchers have prepared an online video protocol in conjunction with a manuscript entitled, “A Lectin HPLC Method to Enrich Selectively-glycosylated Peptides from Complex Biological Samples.” No subscription is required. Read more.
CPTC Leads Data Sharing Policy Efforts
Advancements in science and health care are made possible through widespread access to data from cutting-edge research, enabling scientists to use and build on this knowledge. CPTC is leading these efforts in the proteomics research community. Read more.
eProtein Newsletter – Summer 2009
The Summer 2009 issue of eProtein, the CPTC Newsletter, is now available online.
Read the newsletter
New CPTAC Center Network Study Reveals Biomarker Method That Could Increase the Number of Diagnostic Tests for Cancer
A team of CPTAC researchers has demonstrated that a new method for detecting and quantifying protein biomarkers in body fluids may ultimately make it possible to screen multiple biomarkers in hundreds of patient samples, thus ensuring that only the strongest biomarker candidates will advance down the development pipeline. The study results, published in the online version of Nature Biotechnology on June 28, 2009, show that new applications of existing proteomic techniques show promise of greater accuracy and may eliminate a major roadblock in the development of diagnostic tests for cancer.
Read more
CPTC Leads Data Sharing Policy Efforts: The Amsterdam Principles
Working with the international community, CPTC has led efforts to provide recommendations for rapid proteomics data release and sharing policies that are similar to the Bermuda Principles, which served as a catalyst in the world of genomics. Read the white paper.
Data Sharing Policies Being Recognized as Important for Innovation
In a recent Scientific American worldVIEW article, "Sharing the Wealth of Data," Dr. Rodriguez helps shed light on the importance of data sharing policies, stating that "advances in science and healthcare are made possible through widespread and barrier-free access to research and the data produced by that research." Read the article.
New Funding through the American Recovery and Reinvestment Act (ARRA)
The NCI has launched a dedicated Web site in response to the American Recovery and Reinvestment Act of 2009 (ARRA), including funding opportunities in proteomics. Read more
Proteomics Podcast – The Promise of Proteomics for Personalized Medicine
Dr. Henry Rodriguez, Director of CPTC, offers his perspective on the potential for using new proteomics research to significantly advance the field of cancer research and to develop targeted therapies. Read more
Promise and Reality of Proteomics Webinar
Dr. Henry Rodriguez, Director of CPTC, and other speakers discuss the challenges facing clinical proteomics and the innovative ways that NCI's Clinical Proteomic Technologies for Cancer (CPTC) aims to develop new, more refined, efficient, and reliable biomarker discovery and verification pipelines. Read more
